Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 14645850.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vancomycin is usually reserved for treatment of serious infections, including those caused by multidrug-resistant Staphylococcus aureus. A clinical isolate of S. aureus with high-level resistance to vancomycin (minimal inhibitory concentration = 1024 microg/ml) was isolated in June 2002. This isolate harbored a 57.9-kilobase multiresistance conjugative plasmid within which Tn1546 (vanA) was integrated. Additional elements on the plasmid encoded resistance to trimethoprim (dfrA), beta-lactams (blaZ), aminoglycosides (aacA-aphD), and disinfectants (qacC). Genetic analyses suggest that the long-anticipated transfer of vancomycin resistance to a methicillin-resistant S. aureus occurred in vivo by interspecies transfer of Tn1546 from a co-isolate of Enterococcus faecalis.
Medical subject headings
- Bacterial Proteins
- Carbon-Oxygen Ligases
- DNA Transposable Elements
- Enterococcus faecalis
- R Factors
- Staphylococcus aureus
- Vancomycin Resistance